Last update 21 Nov 2024
Human prothrombin complex concentrate(Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Non-recombinant coagulation factor |
Synonyms- |
Mechanism F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators), factor VII modulators(Coagulation factor VII modulators) + [1] |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Human prothrombin complex concentrate(Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.)评价人凝血酶原复合物在血友病B患者出血事件中按需治疗有效性和安全性的单臂、开放、多中心Ⅲ期临床试验
[Translation] A single-arm, open-label, multicenter phase III clinical trial to evaluate the efficacy and safety of human prothrombin complex on-demand treatment of bleeding events in patients with hemophilia B
100 Clinical Results associated with Human prothrombin complex concentrate(Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Human prothrombin complex concentrate(Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Human prothrombin complex concentrate(Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.)
Login to view more data
1
Literatures (Medical) associated with Human prothrombin complex concentrate(Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.)01 Apr 1986Journal of Chromatography B: Biomedical Sciences and Applications
Affinity chromatography of thrombin on modified polystyrene resins
Article
Author: D. Muller ; A. Bros ; J. Jozefonvicz ; A.M. Fischer ; J. Tapon-Bretaudiere ; X.J. Yu
100 Deals associated with Human prothrombin complex concentrate(Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Blood Coagulation Disorders | NDA/BLA | CN | 29 Apr 2022 | |
| Hemophilia B | Phase 3 | CN | 26 Sep 2024 | |
| Acquired coagulation factor deficiency | IND Approval | CN | 29 Aug 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free